Article de Périodique
Synthetic cannabinoid use in an adult male prison in the UK (2023)
Auteur(s) :
CRAFT, S. ;
AUSTIN, A. ;
TOOTH, T. ;
GLOVER, C. ;
GARRETT, T. ;
BLAGBROUGH, I. S. ;
SUNDERLAND, P. ;
PUDNEY, C. R. ;
FREEMAN, T. P.
Année
2023
Page(s) :
art. 104219
Langue(s) :
Anglais
Domaine :
Drogues illicites / Illicit drugs
Discipline :
EPI (Epidémiologie / Epidemiology)
Thésaurus géographique
ROYAUME-UNI
Thésaurus mots-clés
PRISON
;
CANNABINOIDES
;
DROGUES DE SYNTHESE
;
SEXE MASCULIN
;
PSYCHOPATHOLOGIE
;
ETUDE TRANSVERSALE
;
PROFIL SOCIO-DEMOGRAPHIQUE
;
MOTIVATION
;
TYPE D'USAGE
;
VOIE D'ADMINISTRATION
;
ACHAT
;
TRAFIC
;
EFFET RECHERCHE
Résumé :
Introduction: Synthetic cannabinoids (i.e. Spice) are a major public health problem in UK prisons, however, research in this area is limited. Here we aimed to draw comparisons between people with and without experience of using synthetic cannabinoids in prison, to characterise the features of, and motivations for use within this setting and evaluate support for different treatment interventions.
Method: Questionnaires were administered to 122 people in a category-B prison for adult males in England between July 2022 and March 2023. Participants were asked questions related to their sociodemographic and custodial characteristics, use of synthetic cannabinoids (and other drugs) inside and outside of prison and psychological distress was measured via the Brief Symptom Inventory (BSI-18). Those that had ever used synthetic cannabinoids in prison completed additional questions related to features of use, motivations for use and support for various interventions.
Results: In total 46.7 % (n = 57) of participants reported use of synthetic cannabinoids in prison and this group experienced significantly greater levels of psychological distress compared to those reporting no use (mean (+/- standard deviation) BSI-18 scores = 23.7 (+/-16.7) vs 12.8 (+/-13.6), p < 0.001). Participants mostly reported using paper-based preparations (77.4%) and use via e-cigarettes (75.9%). The most strongly endorsed motivations for use included to alleviate boredom (91.1 % strongly agree/agree), to make the sentence pass faster (89.3% strongly agree/agree) and to cope with stress (80.4 % strongly agree/agree). The interventions that received most support were strategies to better manage time and medication to manage withdrawal.
Conclusions: The use of synthetic cannabinoids in UK prisons typically involves the use of paper-based preparations via e-cigarettes, and use is associated with greater levels of psychological distress. Motivations for use were mostly pragmatic (e.g. to alleviate boredom or cope with stress) and interventions should prioritise increasing the time individuals spend out of cells and in meaningful activity.
Method: Questionnaires were administered to 122 people in a category-B prison for adult males in England between July 2022 and March 2023. Participants were asked questions related to their sociodemographic and custodial characteristics, use of synthetic cannabinoids (and other drugs) inside and outside of prison and psychological distress was measured via the Brief Symptom Inventory (BSI-18). Those that had ever used synthetic cannabinoids in prison completed additional questions related to features of use, motivations for use and support for various interventions.
Results: In total 46.7 % (n = 57) of participants reported use of synthetic cannabinoids in prison and this group experienced significantly greater levels of psychological distress compared to those reporting no use (mean (+/- standard deviation) BSI-18 scores = 23.7 (+/-16.7) vs 12.8 (+/-13.6), p < 0.001). Participants mostly reported using paper-based preparations (77.4%) and use via e-cigarettes (75.9%). The most strongly endorsed motivations for use included to alleviate boredom (91.1 % strongly agree/agree), to make the sentence pass faster (89.3% strongly agree/agree) and to cope with stress (80.4 % strongly agree/agree). The interventions that received most support were strategies to better manage time and medication to manage withdrawal.
Conclusions: The use of synthetic cannabinoids in UK prisons typically involves the use of paper-based preparations via e-cigarettes, and use is associated with greater levels of psychological distress. Motivations for use were mostly pragmatic (e.g. to alleviate boredom or cope with stress) and interventions should prioritise increasing the time individuals spend out of cells and in meaningful activity.
Affiliation :
Addiction and Mental Health Group, Department of Psychology, University of Bath, UK
HM Prison and Probation Service (HMPPS), London, UK
Royal College of General Practitioners Secure Environments Group, London, UK
Office of Health Improvements and Disparities (OHID), London, UK
Department of Life Sciences, University of Bath, Bath, UK
HM Prison and Probation Service (HMPPS), London, UK
Royal College of General Practitioners Secure Environments Group, London, UK
Office of Health Improvements and Disparities (OHID), London, UK
Department of Life Sciences, University of Bath, Bath, UK
Cote :
Abonnement
Historique